IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside
International Immunopharmacology · 2024-05 · 133 · 112156
DOI: 10.1016/j.intimp.2024.112156 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2024-05. Verfasst von Sogand Vahidi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: so.vahidii@gmail.com. Hauptthemen laut MEDLINE: Interleukin-15, Killer Cells, Natural, Neoplasms, Immunotherapy. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 153 Literaturangaben.
Abstract (Originalsprache)
Interleukin 15 (IL-15) has emerged as a crucial factor in the relationship between natural killer (NK) cells and immunotherapy for cancer. This review article aims to provide a comprehensive understanding of the role of IL-15 in NK cell-mediated immunotherapy. First, the key role of IL-15 signaling in NK cell immunity is discussed, highlighting its regulation of NK cell functions and antitumor properties. Furthermore, the use of IL-15 or its analogs in clinical trials as a therapeutic strategy for various cancers, including the genetic modification of NK cells to produce IL-15, has been explored. The potential of IL-15-based therapies, such as chimeric antigen receptor (CAR) T and NK cell infusion along with IL-15 in combination with checkpoint inhibitors and other treatments, has been examined. This review also addresses the challenges and advantages of incorporating IL-15 in cell-based immunotherapy. Additionally, unresolved questions regarding the detection and biological significance of the soluble IL-15/IL-15Rα complex, as well as the potential role of IL-15/IL-15Rα in human cancer and the immunological consequences of prolonged exposure to soluble IL-15 for NK cells, are discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran. Electronic address: so.vahidii@gmail.com.
- Department of Chemistry, Lahijan Branch, Islamic Azad University, Lahijan, Iran.
- Guilan Road Trauma Research Center, Trauma Institute, Guilan University of Medical Sciences, Rasht, Iran. Electronic address: a.a.hormoz@gmail.com.
Zitieren
APA
Vahidi, S., Zabeti Touchaei, A., & Samadani, A. A. (2024). IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside. International Immunopharmacology, 133, 112156. https://doi.org/10.1016/j.intimp.2024.112156
Vancouver
Vahidi S, Zabeti Touchaei A, Samadani AA. IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside. International Immunopharmacology. 2024;133:112156. doi:10.1016/j.intimp.2024.112156
BibTeX
@article{Vahidi2024,
author = {Vahidi, Sogand and Zabeti Touchaei, Arefeh and Samadani, Ali Akbar},
title = {IL-15 as a key regulator in NK cell-mediated immunotherapy for cancer: From bench to bedside},
journal = {International Immunopharmacology},
year = {2024},
volume = {133},
pages = {112156},
doi = {10.1016/j.intimp.2024.112156}
}
EUVIMED